Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivera Finn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|January 8, 2026
Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemicOlivera Finn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Advances in immuno-oncology. ForewordAlexander Eggermont, Olivera Finn
Frontiers in Immunology|June 29, 2026
Editorial: Cancer ImmunosurveillanceSam Hanash, Luigi Buonaguro, Olivera Finn
Oncoimmunology|January 27, 2022
LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumorsCamille Jacqueline, Matthew Dracz, Jia Xue, et al.
European Journal of Immunology|November 25, 2003
O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cellsFranz-Georg Hanisch, Tilo Schwientek, Michael S Von Bergwelt-Baildon, et al.
Immunity|June 9, 2026
Communicating scienceShruti Naik, Josep Tabernero, Fabienne Mackay, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicFrank L Meyskens, Gregory A Curt, Dean E Brenner, et al.
Journal of Leukocyte Biology|May 27, 2005
Autoantigens act as tissue-specific chemoattractantsJoost J Oppenheim, Hui Fang Dong, Paul Plotz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|January 8, 2026
Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemicOlivera Finn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Advances in immuno-oncology. ForewordAlexander Eggermont, Olivera Finn
Frontiers in Immunology|June 29, 2026
Editorial: Cancer ImmunosurveillanceSam Hanash, Luigi Buonaguro, Olivera Finn
Oncoimmunology|January 27, 2022
LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumorsCamille Jacqueline, Matthew Dracz, Jia Xue, et al.
European Journal of Immunology|November 25, 2003
O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cellsFranz-Georg Hanisch, Tilo Schwientek, Michael S Von Bergwelt-Baildon, et al.
Immunity|June 9, 2026
Communicating scienceShruti Naik, Josep Tabernero, Fabienne Mackay, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicFrank L Meyskens, Gregory A Curt, Dean E Brenner, et al.
Journal of Leukocyte Biology|May 27, 2005
Autoantigens act as tissue-specific chemoattractantsJoost J Oppenheim, Hui Fang Dong, Paul Plotz, et al.
Pageof 1